Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • Carl Zeiss Meditec AG accounts for 4.77 % of our European Portfolio. A trade is currently open since 05/03/2019 with a purchase price of € 86.90. Discover the other 19 stocks of the European portfolio managed by the MarketScreener portfolio management team.
Strengths
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • The group usually releases upbeat results with huge surprise rates.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 73.95 EUR
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at EUR 89.55.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 49.48 times its estimated earnings per share for the ongoing year.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
Ratings chart
Sector Advanced Medical Equipment & Technology - NEC
1st jan.Capitalisation (M$)Investor Rating
CARL ZEISS MEDITEC AG27.67%8 514
THERMO FISHER SCIENTIFIC31.58%106 107
DANAHER CORPORATION37.85%94 446
BOSTON SCIENTIFIC CORPORATI..17.97%53 248
INTUITIVE SURGICAL9.79%52 907
ILLUMINA19.27%44 647
SIEMENS HEALTHINEERS AG3.74%39 215
ROYAL PHILIPS22.07%37 196
EDWARDS LIFESCIENCES CORPOR..25.19%35 199
SHENZHEN MINDRAY BIO-MEDL E..--.--%25 963
CERNER CORPORATION37.47%22 480
AGILENT TECHNOLOGIES8.42%21 168
OLYMPUS CORP-63.67%16 635
RESMED5.44%16 169
WATERS CORPORATION12.81%13 866
HOLOGIC19.37%11 810
More Results
Financials (€)
Sales 2019 1 408 M
EBIT 2019 237 M
Net income 2019 161 M
Finance 2019 663 M
Yield 2019 0,70%
P/E ratio 2019 49,48
P/E ratio 2020 41,40
EV / Sales 2019 5,07x
EV / Sales 2020 4,60x
Capitalization 7 799 M
Upcoming event on CARL ZEISS MEDITEC AG
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus -
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes